Efficacy of the cigarette-burning application combined with medication intervention for smoking cessation in China: A randomized controlled trial
Background Although smartphone application for smoking cessation was considered a promising strategy, there were scarce studies on the combination of usual interventions and apps for smoking cessation in China. Our study aimed to evaluate the efficacy of the Cigarette-Burning application combined wi...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-11-01
|
| Series: | Digital Health |
| Online Access: | https://doi.org/10.1177/20552076241297732 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846157549651361792 |
|---|---|
| author | Xiao-Wen Wei Rui Qin Yong-Zhuang Liu Zhao Liu An-Qi Cheng Xin-Mei Zhou Zheng Su Zi-Yang Cui Jin-Xuan Li Liang Zhao Dan Xiao Chen Wang |
| author_facet | Xiao-Wen Wei Rui Qin Yong-Zhuang Liu Zhao Liu An-Qi Cheng Xin-Mei Zhou Zheng Su Zi-Yang Cui Jin-Xuan Li Liang Zhao Dan Xiao Chen Wang |
| author_sort | Xiao-Wen Wei |
| collection | DOAJ |
| description | Background Although smartphone application for smoking cessation was considered a promising strategy, there were scarce studies on the combination of usual interventions and apps for smoking cessation in China. Our study aimed to evaluate the efficacy of the Cigarette-Burning application combined with medication intervention for smoking cessation. Methods A parallel, open-label randomized clinical trial was conducted with a ratio of 1:1 allocation into the bupropion plus app group and bupropion group. All participants received bupropion intervention. Besides, participants in the bupropion plus app group were required to download and use the Cigarette-Burning app. Follow-up visits were conducted at weeks 1, 2, 4, 9, 12, and 24 after initiation of treatment. Results Four hundred participants were eventually included and analyzed from July 2019 to June 2021. The continuous abstinence rate at 9–12 weeks was significantly higher in the bupropion plus app group (39.5%) than in the bupropion group (27.5%) (OR = 1.64, 95% CI: 1.04–2.60, p < .05). The similar result was found for the 24-week sustained abstinence rate. The results of subgroup analysis expressed that the 9–12 weeks continuous abstinence rate in the bupropion plus app group was significantly higher than the bupropion group when the age of participants ≥ 50, the education level was college and above, FTND scores > 5, age at starting smoking ≤ 18 ( p < .05). Conclusions Our study found that the intervention combined with the Cigarette-Burning smartphone application is more effective than medication alone, and the application for smoking cessation could be an accessible complement to smoking cessation medication treatment. |
| format | Article |
| id | doaj-art-a3a43b62b1fa4785b82b6c70be0d9a18 |
| institution | Kabale University |
| issn | 2055-2076 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Digital Health |
| spelling | doaj-art-a3a43b62b1fa4785b82b6c70be0d9a182024-11-25T09:03:27ZengSAGE PublishingDigital Health2055-20762024-11-011010.1177/20552076241297732Efficacy of the cigarette-burning application combined with medication intervention for smoking cessation in China: A randomized controlled trialXiao-Wen Wei0Rui Qin1Yong-Zhuang Liu2Zhao Liu3An-Qi Cheng4Xin-Mei Zhou5Zheng Su6Zi-Yang Cui7Jin-Xuan Li8Liang Zhao9Dan Xiao10Chen Wang11 National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Tobacco Control and Prevention of Respiratory Disease, Center of Respiratory Medicine, , Beijing, China Department of Radiology, , Beijing, China , Harbin, China National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Tobacco Control and Prevention of Respiratory Disease, Center of Respiratory Medicine, , Beijing, China National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Tobacco Control and Prevention of Respiratory Disease, Center of Respiratory Medicine, , Beijing, China National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Tobacco Control and Prevention of Respiratory Disease, Center of Respiratory Medicine, , Beijing, China National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Tobacco Control and Prevention of Respiratory Disease, Center of Respiratory Medicine, , Beijing, China Department of Geriatric Medicine, , Beijing, China National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Tobacco Control and Prevention of Respiratory Disease, Center of Respiratory Medicine, , Beijing, China National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Tobacco Control and Prevention of Respiratory Disease, Center of Respiratory Medicine, , Beijing, China National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Tobacco Control and Prevention of Respiratory Disease, Center of Respiratory Medicine, , Beijing, China School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaBackground Although smartphone application for smoking cessation was considered a promising strategy, there were scarce studies on the combination of usual interventions and apps for smoking cessation in China. Our study aimed to evaluate the efficacy of the Cigarette-Burning application combined with medication intervention for smoking cessation. Methods A parallel, open-label randomized clinical trial was conducted with a ratio of 1:1 allocation into the bupropion plus app group and bupropion group. All participants received bupropion intervention. Besides, participants in the bupropion plus app group were required to download and use the Cigarette-Burning app. Follow-up visits were conducted at weeks 1, 2, 4, 9, 12, and 24 after initiation of treatment. Results Four hundred participants were eventually included and analyzed from July 2019 to June 2021. The continuous abstinence rate at 9–12 weeks was significantly higher in the bupropion plus app group (39.5%) than in the bupropion group (27.5%) (OR = 1.64, 95% CI: 1.04–2.60, p < .05). The similar result was found for the 24-week sustained abstinence rate. The results of subgroup analysis expressed that the 9–12 weeks continuous abstinence rate in the bupropion plus app group was significantly higher than the bupropion group when the age of participants ≥ 50, the education level was college and above, FTND scores > 5, age at starting smoking ≤ 18 ( p < .05). Conclusions Our study found that the intervention combined with the Cigarette-Burning smartphone application is more effective than medication alone, and the application for smoking cessation could be an accessible complement to smoking cessation medication treatment.https://doi.org/10.1177/20552076241297732 |
| spellingShingle | Xiao-Wen Wei Rui Qin Yong-Zhuang Liu Zhao Liu An-Qi Cheng Xin-Mei Zhou Zheng Su Zi-Yang Cui Jin-Xuan Li Liang Zhao Dan Xiao Chen Wang Efficacy of the cigarette-burning application combined with medication intervention for smoking cessation in China: A randomized controlled trial Digital Health |
| title | Efficacy of the cigarette-burning application combined with medication intervention for smoking cessation in China: A randomized controlled trial |
| title_full | Efficacy of the cigarette-burning application combined with medication intervention for smoking cessation in China: A randomized controlled trial |
| title_fullStr | Efficacy of the cigarette-burning application combined with medication intervention for smoking cessation in China: A randomized controlled trial |
| title_full_unstemmed | Efficacy of the cigarette-burning application combined with medication intervention for smoking cessation in China: A randomized controlled trial |
| title_short | Efficacy of the cigarette-burning application combined with medication intervention for smoking cessation in China: A randomized controlled trial |
| title_sort | efficacy of the cigarette burning application combined with medication intervention for smoking cessation in china a randomized controlled trial |
| url | https://doi.org/10.1177/20552076241297732 |
| work_keys_str_mv | AT xiaowenwei efficacyofthecigaretteburningapplicationcombinedwithmedicationinterventionforsmokingcessationinchinaarandomizedcontrolledtrial AT ruiqin efficacyofthecigaretteburningapplicationcombinedwithmedicationinterventionforsmokingcessationinchinaarandomizedcontrolledtrial AT yongzhuangliu efficacyofthecigaretteburningapplicationcombinedwithmedicationinterventionforsmokingcessationinchinaarandomizedcontrolledtrial AT zhaoliu efficacyofthecigaretteburningapplicationcombinedwithmedicationinterventionforsmokingcessationinchinaarandomizedcontrolledtrial AT anqicheng efficacyofthecigaretteburningapplicationcombinedwithmedicationinterventionforsmokingcessationinchinaarandomizedcontrolledtrial AT xinmeizhou efficacyofthecigaretteburningapplicationcombinedwithmedicationinterventionforsmokingcessationinchinaarandomizedcontrolledtrial AT zhengsu efficacyofthecigaretteburningapplicationcombinedwithmedicationinterventionforsmokingcessationinchinaarandomizedcontrolledtrial AT ziyangcui efficacyofthecigaretteburningapplicationcombinedwithmedicationinterventionforsmokingcessationinchinaarandomizedcontrolledtrial AT jinxuanli efficacyofthecigaretteburningapplicationcombinedwithmedicationinterventionforsmokingcessationinchinaarandomizedcontrolledtrial AT liangzhao efficacyofthecigaretteburningapplicationcombinedwithmedicationinterventionforsmokingcessationinchinaarandomizedcontrolledtrial AT danxiao efficacyofthecigaretteburningapplicationcombinedwithmedicationinterventionforsmokingcessationinchinaarandomizedcontrolledtrial AT chenwang efficacyofthecigaretteburningapplicationcombinedwithmedicationinterventionforsmokingcessationinchinaarandomizedcontrolledtrial |